These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6305847)

  • 1. Acquired chemotactic inhibitors during infection with guinea pig cytomegalovirus.
    Tannous R; Myers MG
    Infect Immun; 1983 Jul; 41(1):88-96. PubMed ID: 6305847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chemotactic factor inactivation in neutrophil chemotaxis.
    Tannous R; Cavender-Zylich N; Ginsberg BH
    J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of glycogen-induced guinea pig polymorphonuclear leukocytes to detect inhibitors of chemotaxis found in human serum.
    Judd RC; Rudbach JA
    Diagn Immunol; 1985; 3(1):1-6. PubMed ID: 3995877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
    Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
    Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
    Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired migratory and chemotactic activity of neutrophils during murine cytomegalovirus infection.
    Bale JF; Kern ER; Overall JC; Baringer JR
    J Infect Dis; 1983 Sep; 148(3):518-25. PubMed ID: 6311912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil chemotaxis in patients with Staphylococcus aureus furunculosis.
    Cates KL; Quie PG
    Infect Immun; 1979 Dec; 26(3):1004-8. PubMed ID: 393626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil response and function during acute cytomegalovirus infection in guinea pigs.
    Yourtee EL; Bia FJ; Griffith BP; Root RK
    Infect Immun; 1982 Apr; 36(1):11-6. PubMed ID: 6281184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis.
    Matzner Y; Marx G; Drexler R; Eldor A
    Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms.
    Ward PA; Dvorak HF; Cohen S; Yoshida T; Data R; Selvaggio SS
    J Immunol; 1975 May; 114(5):1523-31. PubMed ID: 1091704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of neutrophil and monocyte specific chemotactic factors derived from the cornea in response to hydrogen peroxide injury.
    Elgebaly SA; Herkert N; O'Rourke J; Kreutzer DL
    Am J Pathol; 1987 Jan; 126(1):40-50. PubMed ID: 3812638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity.
    Schröder JM; Mrowietz U; Christophers E
    J Immunol; 1988 May; 140(10):3534-40. PubMed ID: 3283239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation.
    Doherty DE; Henson PM; Clark RA
    J Clin Invest; 1990 Oct; 86(4):1065-75. PubMed ID: 2212000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of eosinophil leukocyte chemotaxis by a factor in normal human serum (SEF).
    Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1979; 60(3):315-24. PubMed ID: 489135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release.
    Ogawa H; Kunkel SL; Fantone JC; Ward PA
    Am J Pathol; 1981 Nov; 105(2):149-55. PubMed ID: 7294162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.